Innocoll (NASDAQ:INNL) Receives Media Sentiment Rating of 0.09

News articles about Innocoll (NASDAQ:INNL) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innocoll earned a coverage optimism score of 0.09 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 45.2634723900683 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Shares of Innocoll (NASDAQ INNL) opened at $2.35 on Monday. The company has a current ratio of 1.01, a quick ratio of 0.86 and a debt-to-equity ratio of -2.26. Innocoll has a 1 year low of $0.53 and a 1 year high of $6.51. The stock has a market cap of $70.73 and a price-to-earnings ratio of -1.42.

ILLEGAL ACTIVITY WARNING: “Innocoll (NASDAQ:INNL) Receives Media Sentiment Rating of 0.09” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at

About Innocoll

Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.

Insider Buying and Selling by Quarter for Innocoll (NASDAQ:INNL)

Receive News & Ratings for Innocoll Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll and related companies with's FREE daily email newsletter.

Leave a Reply